Skip to main content
. 2018 Jun 14;2:PO.18.00025. doi: 10.1200/PO.18.00025

Fig 2.

Fig 2.

Diagram outlining the entire treatment history with corresponding CA-125 levels. CP, carboplatin and paclitaxel; GP, carboplatin and gemcitabine; PLD, liposomal doxorubicin.